Literature DB >> 6791433

Serum immunoglobulins in homozygous beta-thalassemia.

P A Tovo, R Miniero, C Barbera, L Sacchetti, M Saitta.   

Abstract

IgG, IgA and IgM levels were studied in 187 homozygous beta-thalassemic patients and compared with age-matched normal control subjects. The not yet transfused and the polytransfused nonsplenectomized patients showed a significant increase of all Ig classes. The polytransfused splenectomized patients showed a significant increase only of IgG and IgA. The splenectomized patients, when compared to the nonsplenectomized ones, showed a significant increase of IgG, of IgA in the elder ones and a significant reduction of IgM. High ASLO and ASFLO titers were found especially in the splenectomized patients. The high Ig levels in younger not yet transfused patients, with little iron storage and normal hepatic enzyme values, demonstrate that transfusion therapy and liver damage do not play a main role in hypergammaglobulinemia. The absence of antimitochondrial, anticonnective tissue and homogeneous antinuclear antibodies seems to exclude a deficient suppressor mechanism. The hemocatheteric "overworking' of RES may reduce the antigen clearance with a consequent increase of antibody response. Splenectomy, by removing a consistent part of RES, enhances the phenomenon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791433     DOI: 10.1159/000207144

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

1.  Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.

Authors:  A N Akbar; P J Giardina; M W Hilgartner; R W Grady
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

2.  The sicca syndrome in thalassaemia major.

Authors:  C Borgna-Pignatti; V Cammareri; P De Stefano; U Magrini
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

3.  Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon.

Authors:  A N Akbar; P A Fitzgerald-Bocarsly; P J Giardina; M W Hilgartner; R W Grady
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

4.  Abnormalities in the immune system of children with beta-thalassaemia major.

Authors:  J Dwyer; C Wood; J McNamara; A Williams; W Andiman; L Rink; T O'Connor; H Pearson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia.

Authors:  Mojgan Kiani-Amin; Mohammadmehdi Daneshi; Parviz Ayazi; Shima Mohammadian; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

6.  Comparative plasma protein profiling of hemoglobin H disease.

Authors:  Kamonlak Leecharoenkiat; Wannapa Sornjai; Kornpat Khungwanmaythawee; Atchara Paemanee; Chartchai Chaichana; Sittiruk Roytrakul; Suthat Fucharoen; Saovaros Svasti; Duncan R Smith
Journal:  Dis Markers       Date:  2014-06-15       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.